Status:

UNKNOWN

Chlorhexidine Gluconate for Prevention of Ventilator Associated Pneumonia in Children.

Lead Sponsor:

Sinaloa Pediatric Hospital

Conditions:

Mechanical Ventilation for More Than 48 Hours.

Eligibility:

All Genders

1-18 years

Phase:

PHASE4

Brief Summary

To determine the efficacy of prophylaxis with 0.12% chlorhexidine gluconate compared with placebo to prevent ventilator associated pneumonia in children admitted to a pediatric critical care unit.

Detailed Description

Randomised controlled trial to determine the efficacy of 0.12% chlorhexidine gluconate compared with placebo to prevent ventilator associated pneumonia in children admitted to a pediatric critical car...

Eligibility Criteria

Inclusion

  • Children aged 1 month to 18 years admitted to the intensive care unit.
  • Intubated for more than 48 hours.

Exclusion

  • Clinical or radiological diagnosis of pneumonia previous to the endotracheal intubation.
  • Allergy to chlorhexidine.
  • Known immune deficiency.
  • Elimination Criteria:
  • Transfer to another hospital.

Key Trial Info

Start Date :

October 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2016

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT01883596

Start Date

October 1 2012

End Date

December 1 2016

Last Update

December 8 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sinaloa Pediatric Hospital

Culiacán, Sinaloa, Mexico, 80200